An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...

Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.

Five more rare diseases have been identified in the country, making the total number of rare diseases reach 456, according to ...

Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, ...

Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...

Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...

Report recommended that strategies should be developed to prioritise ongoing education for healthcare professionals to ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

For the first time since 2018, the Navesink River was frozen enough for ice boaters to take their crafts out on the solid ...

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...